Skip to main content
Premium Trial:

Request an Annual Quote

Congenica, Edico Genome Bundle Technology

NEW YORK (GenomeWeb) – British genomics analysis startup Congenica and San Diego-based sequencing informatics firm Edico Genome are partnering to offer their products as a technology bundle. Together, they hope to help laboratories and hospitals accelerate the movement of genomics from sequencing to diagnosis of inherited diseases.

The partnership also will help Cambridge-based Congenica expand its presence in the US.

Specifically, the two companies are combining Congenica's Sapientia genome-analysis software with Edico’s field-programmable gate array bioinformatics processor, Dragen. They expect to be able to reduce "DNA-to-diagnosis" time from months to minutes.

"By combining our complementary technologies, we aim to accelerate the clinician's ability to use genomics to diagnose a patient's disease, and make this available on a global basis," Congenica CEO Thomas Weaver said in a statement.

In January, Edico Genome inked a deal with Dell EMC to integrate the Dragen processor into a 1U Dell 4130 server for genome analysis, as well as Dell EMC's Isilon scale-out networked attached storage for genomic data storage.

In late February, Congenica announced that it raised a $10 millon Series B round of venture capital.

The Scan

Close Panel Vote on Califf Nomination

The New York Times reports there was a close committee vote to advance the nomination of Robert Califf to lead the US Food and Drug Administration to the full Senate.

Task Force Reports on Scientific Integrity

Nature News writes that that a new task force report recommends that the US establish a cross-agency scientific integrity council.

Across the Hall

Genetic testing, closed-circuit cameras, and more show how a traveler, without any contact, infected others at a New Zealand quarantine facility, CNN reports.

Science Paper Examines Influence of Chromatin Modifications on Obsessive-Compulsive Disorder

In Science this week: genes regulating chromatin modification may contribute to OCD risk.